Phase I trial of continuous Taxotere, Adriamycin, and cyclophosphamide with G-CSF (conTAC).

被引：0
|
作者：
Budd, GT [1 ]
Peereboom, D [1 ]
Weiss, P [1 ]
Elson, P [1 ]
机构：
[1] Cleveland Clin Fdn, Ctr Canc, Cleveland, OH 44195 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
354
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [21] Randomized trial of MAID (Mesna, Adriamycin, Ifosfamide, Decarbazine) chemotherapy with G-CSF alone or with G-CSF plus varying doses of interleukin-6 (IL-6).
    Budd, GT
    Samuels, B
    Gockerman, J
    Baker, L
    Margolin, K
    Zalupski, M
    Felser, J
    Johnson, B
    Isaacs, R
    Bukowski, RM
    BLOOD, 1996, 88 (10) : 3281 - 3281
  • [22] Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice
    Matsuzaki, G
    Li, XY
    Ohyama, Y
    Nomoto, K
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1996, 18 (6-7): : 363 - 369
  • [23] Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children (vol 2016, 4078215, 2016)
    Vazquez Meraz, Jose Eugenio
    Arellano-Galindo, Jose
    Martinez Avalos, Armando
    Mendoza-Garcia, Emma
    Jimenez-Hernandez, Elva
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [24] Prospective randomised study of PBSC mobilisation using intermediate dose cyclophosphamide and G-CSF versus G-CSF alone.
    Karanth, M
    Harvey, C
    Chakrabarti, S
    Holder, K
    McConkey, CC
    McDonald, D
    Lovell, RA
    Fegan, CD
    Milligan, DW
    BLOOD, 2002, 100 (11) : 826A - 826A
  • [25] A randomized phase II study of stem cell mobilization with cyclophosphamide plus G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma
    Silvennoinen, R.
    Anttila, P.
    Saily, M.
    Lundan, T.
    Heiskanen, J.
    Siitonen, T. M.
    Kakko, S.
    Putkonen, M.
    Ollikainen, H.
    Terava, V.
    Kutila, A.
    Launonen, K.
    Rasanen, A.
    Sikio, A.
    Suominen, M.
    Bazia, P.
    Kananen, K.
    Selander, T.
    Kuittinen, T.
    Remes, K.
    Jantunen, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 372 - 376
  • [26] LOW DOSE POSTTRANSPLANTATION CYCLOPHOSPHAMIDE CAN ENHANCE THE PROTECTIVE EFFECT OF ATG /G-CSF ON GVHD: RESULTS OF A PHASE II PROSPECTIVE TRIAL
    Wang, Y.
    Chang, Y. -J.
    Huang, X. -J.
    HAEMATOLOGICA, 2017, 102 : 618 - 619
  • [27] Phase I study of cyclophosphamide and docetaxel (Taxotere(R)) in solid tumors
    Valero, V
    Esparza, L
    Patel, S
    Theriault, R
    Pazdur, R
    Ayoub, JP
    Qasim, M
    Rodriguez, E
    Bellet, R
    Hortobagyi, G
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 972 - 972
  • [28] Cytarabine plus G-CSF is more effective than cyclophosphamide plus G-CSF as a stem cell mobilization regimen in multiple myeloma
    Jelinek, Tomas
    Adamusova, Lucie
    Popkova, Tereza
    Tvrda, Ivana
    Smejkalova, Jana
    Simicek, Michal
    Salounova, Dana
    Kascak, Michal
    Mihalyova, Jana
    Plonkova, Hana
    Duras, Juraj
    Navratil, Milan
    Hajek, Roman
    Koristek, Zdenek
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1107 - 1114
  • [29] G-CSF Alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment
    G Milone
    S Leotta
    F Indelicato
    S Mercurio
    G Moschetti
    F Di Raimondo
    A Tornello
    U Consoli
    G Guido
    R Giustolisi
    Bone Marrow Transplantation, 2003, 31 : 747 - 754
  • [30] G-CSF Alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma:: results depend on degree of previous pretreatment
    Milone, G
    Leotta, S
    Indelicato, F
    Mercurio, S
    Moschetti, G
    Di Raimondo, F
    Tornello, A
    Consoli, U
    Guido, G
    Giustolisi, R
    BONE MARROW TRANSPLANTATION, 2003, 31 (09) : 747 - 754
12345